Covered recipient · General Payments record
SA VANNA FERN ROSE BAKER LEYVA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$3,086.42
- Reported across 155 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $922.09 | 53 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $364.82 | 30 |
| Lilly USA, LLC | $206.32 | 5 |
| GlaxoSmithKline, LLC. | $109.05 | 5 |
| Amgen Inc. | $52.08 | 3 |
| Novo Nordisk AS | $46.88 | 2 |
| PFIZER INC. | $41.04 | 2 |
| HARMONY BIOSCIENCES LLC | $31.49 | 2 |
| Philips Electronics North America Corporation | $21.58 | 1 |
| DEXCOM, INC. | $20.95 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.67 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.01 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269305 | CMS |
| ABBVIE INC. | $28.32 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269307 | CMS |
| ABBVIE INC. | $12.53 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269309 | CMS |
| ABBVIE INC. | $13.73 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269311 | CMS |
| ABBVIE INC. | $15.89 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269313 | CMS |
| ABBVIE INC. | $2.88 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269315 | CMS |
| ABBVIE INC. | $25.64 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269317 | CMS |
| ABBVIE INC. | $5.90 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269319 | CMS |
| ABBVIE INC. | $13.26 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269321 | CMS |
| ABBVIE INC. | $20.70 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269323 | CMS |
| ABBVIE INC. | $11.25 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269325 | CMS |
| ABBVIE INC. | $10.97 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269327 | CMS |
| ABBVIE INC. | $13.99 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269329 | CMS |
| ABBVIE INC. | $13.61 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269331 | CMS |
| ABBVIE INC. | $30.68 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269333 | CMS |
| ABBVIE INC. | $32.75 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269335 | CMS |
| ABBVIE INC. | $1.63 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269337 | CMS |
| ABBVIE INC. | $11.36 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269339 | CMS |
| ABBVIE INC. | $26.98 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269341 | CMS |
| ABBVIE INC. | $8.22 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269343 | CMS |
| ABBVIE INC. | $2.19 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269345 | CMS |
| ABBVIE INC. | $12.71 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269347 | CMS |
| ABBVIE INC. | $1.88 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269349 | CMS |
| ABBVIE INC. | $11.11 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269351 | CMS |
| ABBVIE INC. | $0.90 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269353 | CMS |
| ABBVIE INC. | $11.22 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269355 | CMS |
| ABBVIE INC. | $4.04 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269357 | CMS |
| ABBVIE INC. | $5.53 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269359 | CMS |
| ABBVIE INC. | $1.85 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269361 | CMS |
| ABBVIE INC. | $4.09 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269363 | CMS |
| Amgen Inc. | $24.10 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115437529 | CMS |
| Amgen Inc. | $14.00 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117500226 | CMS |
| Amgen Inc. | $13.98 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117500228 | CMS |
| Dexcom, Inc. | $20.95 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153333141 | CMS |
| GlaxoSmithKline, LLC. | $15.85 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116250356 | CMS |
| GlaxoSmithKline, LLC. | $25.00 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116597239 | CMS |
| GlaxoSmithKline, LLC. | $23.00 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116690829 | CMS |
| GlaxoSmithKline, LLC. | $16.28 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115893164 | CMS |
| GlaxoSmithKline, LLC. | $28.92 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116105877 | CMS |
| Harmony Biosciences Llc | $30.00 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141478410 | CMS |
| Harmony Biosciences Llc | $1.49 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141470240 | CMS |
| Lilly USA, LLC | $24.03 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135340769 | CMS |
| Lilly USA, LLC | $24.80 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135368626 | CMS |
| Lilly USA, LLC | $33.36 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135383435 | CMS |
| Lilly USA, LLC | $14.64 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135408833 | CMS |
| Lilly USA, LLC | $109.49 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135368628 | CMS |
| Novo Nordisk Inc | $26.78 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097269394 | CMS |
| Novo Nordisk Inc | $20.10 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097015109 | CMS |
| PFIZER INC. | $20.72 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132032791 | CMS |
| PFIZER INC. | $20.32 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131209726 | CMS |
| Philips North America LLC | $21.58 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146864134 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.21 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137479052 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.67 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144611868 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.